This inventor holds 26 USPTO granted patents and 16 published patent applications, plus 1 CIPO patent and 7 EPO patents, primarily in Targeted Protein Degradation. Top assignees: C4 Therapeutics, Inc., Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Watertown, MA (US) (2020 - 2024)
- Boston, MA (US) (2021 - 2024)
- Cambridge, MA (US) (2021 - 2024)
Company Filing History:
13 out of 40 
8 out of 12,268 
8 out of 387 
Years Active: 2020-2026
Areas of Expertise:
Hello! I'm delighted to present to you an insightful article on the accomplished inventor Kiel Lazarski based in Boston, MA.
Title: Unveiling the Innovations of Kiel Lazarski: A Trailblazing Inventor in Boston, MA
Introduction: Meet Kiel Lazarski, a distinguished inventor hailing from Boston, MA, with an impressive portfolio of 7 patents to his name.
Latest Patents:
1. *2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds:* Kiel Lazarski's inventive prowess shines through in these compounds, which act as selective allosteric inhibitors of T790M and C797S containing EGFR mutants. They are pivotal in the field of pharmaceuticals as therapeutically active substances.
2. *Isoindolinone and indazole compounds for the degradation of EGFR:* Lazarski's innovation introduces compounds that contribute to the degradation of the epidermal growth factor receptor (EGFR), including mutant forms. These compounds play a crucial role in the treatment of various cancers by facilitating proteasomal degradation.
Career Highlights: Kiel Lazarski has leveraged his expertise at notable companies such as C4 Therapeutics, Inc., and Hoffmann-La Roche Inc., where his innovative spirit has flourished, leading to groundbreaking advancements in the realm of pharmaceuticals.
Collaborations: Throughout his career, Lazarski has collaborated with esteemed professionals like Yanke Liang and Andrew J Phillips, fostering a culture of innovation and excellence in his endeavors.
Conclusion: In conclusion, Kiel Lazarski stands as a beacon of innovation, with his groundbreaking patents and collaborations reshaping the landscape of pharmaceutical advancements. His contributions to the field are invaluable, and his inventive spirit continues to inspire future generations of inventors.
I hope you found this article on Kiel Lazarski engaging and informative! If you have any more requests or need further information, feel free to reach out.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile